Cargando…
Inclusion of Strep-Tag II in design of antigen receptors for T cell immunotherapy
The tactical introduction of Strep-tag II into synthetic antigen receptors provides engineered T cells with a marker for identification and rapid purification, and a functional element for selective antibody coated microbead-driven large-scale expansion. Such receptor designs can be applied to chime...
Autores principales: | Liu, Lingfeng, Sommermeyer, Daniel, Cabanov, Alexandra, Kosasih, Paula, Hill, Tyler, Riddell, Stanley R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940167/ https://www.ncbi.nlm.nih.gov/pubmed/26900664 http://dx.doi.org/10.1038/nbt.3461 |
Ejemplares similares
-
Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
por: Berger, S Carolina, et al.
Publicado: (2014) -
Chimeric antigen receptor-modified T cells derived from defined CD8(+) and CD4(+) subsets confer superior antitumor reactivity in vivo
por: Sommermeyer, Daniel, et al.
Publicado: (2015) -
Transtactin: a universal transmembrane delivery system for Strep-tag II-fused cargos
por: Moosmeier, Markus A, et al.
Publicado: (2010) -
Artificial surface labelling of Escherichia coli with StrepTagII antigen to study how monoclonal antibodies drive complement-mediated killing
por: Muts, Remy M., et al.
Publicado: (2023) -
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
por: Sommermeyer, Daniel, et al.
Publicado: (2017)